Literatur
- 1
Ernst E.
Mistletoe as a treatment for cancer.
BMJ.
2006;
333
1282-1283
- 2
Ernst E, Schmidt K, Steuer-Vogt M K.
Mistletoe for cancer? A systematc review of randomised clinical trials.
Int J Cancer.
2003;
107
262-267
- 3
Grossarth-Maticek R, Kiene H, Baumgartner S M, Ziegler R.
Use of iscador, an extract of European mistletoe (viscum album), in cancer treatment:
prospective nonrandomized and randomized matched-pair studies nested within a cohort
study.
Alternat Ther Hlth Med.
2001;
7
57-78
- 4
Horneber M A, Bueschel G, Huber R, Linde K, Rostock M.
Mistletoe therapy in oncology.
Cochrane Database Syst Rev.
2008;
(2)
- 5 IMS Health Data. 2008
- 6
Kienle G S, Berrino F, Büssing A, Portalupi E, Rosenzeig S, Kiene H.
Mistletoe in cancer. A systematic review on controlled clinical trials.
Eur J Med Res.
2003;
8
109-119
- 7
Kienle G S, Glockmann A, Schink M, Kiene H.
Viscum album L. extracts in breast and gynaecological cancers: a systematic review
of clinical and preclinical research.
J Exp Clin Cancer Res.
2009;
28
79
- 8 Kienle G S, Kiene H. Die Mistel in der Onkologie. Stuttgart: Schattauer; 2003
- 9
Kienle G S, Kiene H.
Influence of Viscum album L. (European Mistletoe) extracts on quality of life in cancer.
Integr Cancer Ther.
2010;
9
142
- 10
Kleijnen J, Knipschild P.
Mistletoe treatment for cancer: review of controlled trials in humans.
Phytomedicine.
1994;
1
255-260
- 11
Krüger-Brand H E.
Informationen zur Misteltherapie.
Dtsch Arztebl.
2006;
103
A-2378-B-2062/C-1983
- 12
Mansky P J, Wallerstedt D B, Sannes T et al.
NCCAM/NCI phase I study of mistletoe extract and gemcitabine in patients with advanced
solid tumors.
J Clin Oncol.
2010;
28
(Suppl. 2010 ASCO Annual Meeting Proceedings)
2559
- 13
Münstedt K, Entezami A, Kullmer U.
Onkologische Misteltherapie – zur Anwendung und Bewertung der Wirksamkeit durch Ärzte.
Dtsch Med Wochenschr.
2000;
125
1222-1226
- 14 National Cancer Institute .Mistletoe Extracts (PDQ®). Im Internet: http://www.cancer.gov/cancertopics/pdq/cam/mistletoe/patient Stand 09.06.2011
- 15
Piao B K, Wang Y X, Xie G R, Mansmann U, Matthes H, Beuth J, Lin H S.
Impact of complementary mistletoe extract treatment on quality of life in breast,
ovarian, non small cell lung cancer patients. A prospective randomized controlled
clinical trial.
Anticancer Res.
2004;
24
303-309
- 16 Schwabe U, Paffrath D. Arzneiverordnungsreport. Berlin, Heidelberg, New York: Springer;
2007: 630
- 17
Semiglazov V F, Stepula V V, Dudov A, Schnitker J, Mengs U.
Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract
PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind,
multicentre clinical trial.
Anticancer Res.
2006;
26
1519-1529
Dr. med. Rainer Stange
Abteilung für Naturheilkunde
Charité – Universitätsmedizin
und Immanuel Krankenhaus
Königstraße 63
14109 Berlin
Email: r.stange@immanuel.de
